What is the recommended antimicrobial treatment for bacterial endocarditis?

Treatment for Bacterial Endocarditis

Empirical antibiotic therapy for bacterial endocarditis must be initiated immediately after drawing three sets of blood cultures, with regimen selection based on whether the infection involves a native valve versus prosthetic valve, timing of infection, and acquisition setting (community vs. healthcare-associated). 1

Initial Empirical Therapy (Before Pathogen Identification)

The choice of empirical antibiotics depends critically on three factors:

For Community-Acquired Native Valve or Late Prosthetic Valve Endocarditis (≥12 months post-surgery):

• Ampicillin 12 g/day IV in 4-6 doses
• (Flu)cloxacillin or oxacillin 12 g/day IV in 4-6 doses
• Gentamicin 3 mg/kg/day IV or IM in 1 dose

For penicillin-allergic patients, substitute vancomycin 30-60 mg/kg/day IV in 2-3 doses plus gentamicin 1

For Early Prosthetic Valve Endocarditis (<12 months) or Healthcare-Associated Endocarditis:

• Vancomycin 30 mg/kg/day IV in 2 doses
• Gentamicin 3 mg/kg/day IV or IM in 1 dose
• Rifampin 900-1200 mg IV or orally in 2-3 divided doses (start 3-5 days after vancomycin/gentamicin) 1

This broader regimen covers methicillin-resistant staphylococci, enterococci, and non-HACEK Gram-negative pathogens.

Pathogen-Specific Therapy (Once Identified)

Streptococcal Endocarditis

For highly penicillin-susceptible strains (MIC ≤0.12 μg/mL):

• Penicillin G 24 million units/24h IV continuously or in 4-6 divided doses for 4 weeks (native valve) or 6 weeks (prosthetic valve)
• Alternative: Ceftriaxone 2 g/24h IV for same duration 2

For relatively resistant strains (MIC >0.12 to <0.5 μg/mL):

• Penicillin G 24 million units/24h IV for 4 weeks
• Plus gentamicin 3 mg/kg/day for 2 weeks 2

For highly resistant strains (MIC ≥0.5 μg/mL):

• Treat as enterococcal endocarditis with ampicillin or penicillin plus gentamicin for 4-6 weeks with infectious disease consultation 2

Enterococcal Endocarditis

• Amoxicillin or ampicillin 200 mg/kg/day IV in 4-6 doses for 6 weeks
• Plus gentamicin 3 mg/kg/day IV or IM in 1 dose for 6 weeks
• Alternative: Ceftriaxone 4 g/day IV in 2 doses for 6 weeks (not active against E. faecium) 1

For multiresistant enterococci: Daptomycin 10 mg/kg/day plus ampicillin, or linezolid 600 mg twice daily for ≥8 weeks 1

Staphylococcal Endocarditis

Methicillin-susceptible S. aureus (native valve):

• Nafcillin or oxacillin 12 g/day IV in 4-6 doses for 4-6 weeks
• Alternative: Cefazolin (same duration)
• Consider adding gentamicin for first 3-5 days to accelerate bacteremia clearance 3

Prosthetic valve staphylococcal infection:

• Nafcillin/oxacillin or vancomycin (depending on methicillin susceptibility)
• Plus rifampin 900-1200 mg/day orally (start after 3-5 days of effective therapy)
• Plus gentamicin 3 mg/kg/day for at least 2 weeks
• Total duration: ≥6 weeks 1

HACEK Organisms

• Ceftriaxone 2 g/day IV for 4 weeks (native valve) or 6 weeks (prosthetic valve) 1
• Alternative: Ampicillin 12 g/day plus gentamicin if beta-lactamase negative

Fungal Endocarditis

• Combined antifungal therapy PLUS surgical valve replacement is mandatory
• Mortality exceeds 50% even with optimal treatment 1
• Requires infectious disease specialist consultation

Critical Treatment Principles

Duration of therapy:

• Native valve endocarditis: 2-6 weeks depending on organism
• Prosthetic valve endocarditis: minimum 6 weeks for all organisms 1
• Timing starts from first day of effective therapy (negative blood cultures), NOT from surgery date 1

Monitoring requirements:

• Aminoglycoside serum levels and renal function must be monitored throughout therapy 1
• Vancomycin trough levels should be maintained at appropriate therapeutic ranges 1
• Persistent positive blood cultures at 48-72 hours indicate treatment failure and predict mortality 1

Key pitfalls to avoid:

• Do NOT delay antibiotics to obtain blood cultures if patient is critically ill—draw cultures rapidly and start empirical therapy
• Do NOT use rifampin in early bacteremic phase—wait 3-5 days to avoid antagonism and resistance 1
• Do NOT assume all streptococci are penicillin-susceptible—over 30% of S. mitis and S. oralis show resistance 1

Multidisciplinary Management

All patients with complicated endocarditis should be managed by an Endocarditis Team including cardiology, cardiac surgery, infectious disease, and imaging specialists. This approach has been shown to improve outcomes and is now a cornerstone recommendation 4, 5, 6. Blood culture-negative endocarditis requires mandatory infectious disease consultation 1.

Outpatient parenteral antibiotic therapy (OPAT) may be considered for stable patients after critical complications are controlled, but only after adequate initial intravenous therapy 1.